|
[1]
|
彭雯, 刘时雨, 李铁梅, 等. 《2024世界肥胖报告》解读及对中国相关工作的启示[J]. 中国预防医学杂志, 2024, 25(4): 388-394.
|
|
[2]
|
周颖, 滕井泉, 田乐乐, 等. 丹参及有效化学成分干预肥胖机制的研究进展[J]. 中药材, 2023, 46(11): 2890-2894.
|
|
[3]
|
张蒙蒙, 朱喜妹, 刘绍维, 等. 基于“膏脂-膏浊”理论探析肥胖2型糖尿病的防治[J]. 中医临床研究, 2023, 15(34): 51-54.
|
|
[4]
|
刘维, 卡玉秀. 基于“固本清源”分期诊治痛风[J]. 中医杂志, 2024, 65(18): 1938-1942.
|
|
[5]
|
任雪, 潘赐明, 孙畅, 等. 基于“脾失运化”探讨运脾法调节多囊卵巢综合征内质网应激作用[J]. 世界中医药, 2024, 19(3): 356-361+367.
|
|
[6]
|
Kim, S.O., Yun, S.J. and Lee, E.H. (2007) The Water Extract of Adlay Seed (Coix lachrymajobi var. Mayuen) Exhibits Anti-Obesity Effects through Neuroendocrine Modulation. The American Journal of Chinese Medicine, 35, 297-308.
|
|
[7]
|
Liu, S., Li, F. and Zhang, X. (2019) Structural Modulation of Gut Microbiota Reveals Coix Seed Contributes to Weight Loss in Mice. Applied Microbiology and Biotechnology, 103, 5311-5321. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
吴珍, 魏瑶, 杨玉姣, 等. 23-乙酰泽泻醇b对肥胖模型小鼠糖脂代谢紊乱的改善作用[J]. 中国药房, 2021, 32(9): 1057-1062.
|
|
[9]
|
Ho, C., Gao, Y., Zheng, D., Liu, Y., Shan, S., Fang, B., et al. (2019) Alisol a Attenuates High‐Fat-Diet-Induced Obesity and Metabolic Disorders via the AMPK/ACC/SREBP‐1c Pathway. Journal of Cellular and Molecular Medicine, 23, 5108-5118. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
吕任尧, 郑曙琴. 基于数据挖掘和网络药理学的肥胖用药规律及潜在作用分析[J]. 天津中医药大学学报, 2020, 39(1): 103-110.
|
|
[11]
|
韦伟, 轩妍, 黄晓燕. 茯苓多糖对营养性肥胖幼鼠的降脂和肠道菌群调节作用[J]. 现代食品科技, 2023, 39(10): 35-43.
|
|
[12]
|
逯莉, 王一寓, 席莉. 《中医方剂大辞典》中含陈皮-半夏药对特征分析及现代研究进展[J]. 中国中医基础医学杂志, 2025, 31(10): 1856-1860.
|
|
[13]
|
张理. 陈皮-半夏药对治疗高脂血症作用机制的网络药理学分析与实验研究[J]. 中西医结合心脑血管病杂志, 2022, 20(17): 3118-3128.
|
|
[14]
|
刘志栋, 赵博, 张晓燕, 等. 基于数据挖掘和网络药理学的代谢综合征中医药用药规律及机制分析[J]. 世界科学技术-中医药现代化, 2021, 23(3): 720-730.
|
|
[15]
|
周香珍, 林书发, 何书华. 红曲药学评价研究进展[J]. 中国现代中药, 2016, 18(7): 936-941.
|
|
[16]
|
葛锋, 王艳, 王剑平, 等. 红曲中主要活性成分的研究[J]. 昆明理工大学学报(自然科学版), 2012, 37(2): 61-64.
|
|
[17]
|
Liu, B., Yao, Z., Song, L., Sun, C., Shen, C., Cheng, F., et al. (2025) Vitexin Alleviates Lipid Metabolism Disorders and Hepatic Injury in Obese Mice through the PI3K/AKT/mTOR/SREBP-1c Pathway. European Journal of Medicinal Chemistry, 287, Article 117379. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Yoo, A., Jin Jang, Y., Ahn, J., Hwa Jung, C., Hee Choi, W. and Youl Ha, T. (2019) Lotus Leaf Ethanol Extract and Nuciferine Suppress Adipocyte Differentiation by Regulating AKT-mTORC1 Signaling in 3T3-L1 Cells. Journal of Food and Nutrition Research, 7, 688-695. [Google Scholar] [CrossRef]
|
|
[19]
|
Jia, Q., Zhu, R., Tian, Y., Chen, B., Li, R., Li, L., et al. (2019) Salvia Miltiorrhiza in Diabetes: A Review of Its Pharmacology, Phytochemistry, and Safety. Phytomedicine, 58, Article 152871. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Jung, D.Y., Kim, J.H. and Jung, M.H. (2020) Anti-Obesity Effects of Tanshinone I from Salvia Miltiorrhiza Bunge in Mice Fed a High-Fat Diet through Inhibition of Early Adipogenesis. Nutrients, 12, Article 1242. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Ma, L., Zhao, Z., Guo, X., Li, J., Xu, L., Mei, W., et al. (2022) Tanshinone IIA and Its Derivative Activate Thermogenesis in Adipocytes and Induce “Beiging” of White Adipose Tissue. Molecular and Cellular Endocrinology, 544, Article 111557. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Kong, Y., Yang, H., Nie, R., Zhang, X., Zhang, H. and Nian, X. (2025) Berberine as a Multi-Target Therapeutic Agent for Obesity: From Pharmacological Mechanisms to Clinical Evidence. European Journal of Medical Research, 30, Article No. 477. [Google Scholar] [CrossRef] [PubMed]
|